Pharma biz cops to $5 Billion drug problem

The pharmaceutical industry is now acknowledging that it needs a new marketing strateggy after experiencing waning patience from Congress, incredulousness from the medical community and growing angst among the general public. As a result of this unrest, the Pharmaceutical Research and Manufacturers of America is examining how it brings medications to market.